Mithrl
San Francisco, United States
◆ Total Raised
$20M
◆ Stage
series-a
◆ Location
San Francisco, United States
◆ Founded
2023
◆ Team size
51-200
◆ Links
◆ About Mithrl
AI infrastructure company for biopharma that provides a biomedical world model layered with agentic systems for scientific validation and hypothesis generation.
◆ What sets it apart
It combines a biomedical world model with agentic AI to deliver reproducible, transparent, and auditable scientific decisions inside the customer’s environment.
◆ Sectors
◆ Business
ModelSaaS
CustomerBiopharma, biotech, pharmaceutical, and enterprise life sciences R&D teams
◆ Notable
- Raised a $20M Series A led by Obvious Ventures with participation from Headline, AGI House, and pharma executives
- Previously raised a $4M seed round led by Bonfire Ventures
- Reportedly approaching $1M in revenue in 2024 and serving biotech customers in the U.S. and Europe
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does Mithrl do?
AI infrastructure company for biopharma that provides a biomedical world model layered with agentic systems for scientific validation and hypothesis generation.
Where is Mithrl based?
Mithrl is based in San Francisco, United States, founded in 2023.
How much has Mithrl raised?
Mithrl has raised $20M in tracked funding and is currently at the series-a stage.
Who has invested in Mithrl?
Investors in Mithrl include Obvious Ventures, Headline, AGI House and Bonfire Ventures.